HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Lifang, Yang ^a   Min, Tang ^a   Midan, Ai ^a   Ya, Cao ^a  

^a Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GANCICLOVIR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; THYMIDINE KINASE; ANTIVIRUS AGENT; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; LONG TERMINAL REPEAT; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE; VIRAL GENE THERAPY; ANIMAL; BAGG ALBINO MOUSE; ENZYMOLOGY; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; SUICIDE TRANSGENE; TUMOR CELL LINE; VIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; SIMPLEXVIRUS; TERMINAL REPEAT SEQUENCES; THYMIDINE KINASE; TRANSFECTION; VIRAL MATRIX PROTEINS;

EID: 53649097973     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-42     Document Type: Article

References (19)

1. Epstein-Barr virus and oncogenesis: from latent genes to tumours. LS Yong PG Murray, Oncogene 2003 22 5108 21 10.1038/sj.onc.1206556 12910248
2. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas. KY Jen M Higuchi J Cheng J Li LY Wu YF Li HL Lin Z Chen V Gurtsevitch M Fujii T Saku, Virus Genes 2005 30 223 35 10.1007/s11262-004-5630-5 15744579
3. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. NJ Thornburg W Kulwichit RH Edwards KH Shair KM Bendt N Raab-Traub, Oncogene 2006 25 288 97 16247482
4. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. L Ding LL Li J Yang YG Tao M Ye Y Shi M Tang W Yi XL Li JP Gong Y Cao, Int J Biochem Cell Biol 2005 37 1881 9 10.1016/j.biocel.2005.04.012 15967702
5. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma. C Wang M Ai W Ren H Xiao X Li F Tang H Gu W Yi X Weng X Deng Y Cao, Chin Med J (Engl) 2003 116 1022 8 12890376
6. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. H Zheng LL Li DS Hu XY Deng Y Cao, Cell Mol Immunol 2007 4 185 96 17601372
7. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. SA Williams LF Chen H Kwon CM Ruiz-Jarabo E Verdin WC Greene, EMBO J 2006 25 139 49 16319923 10.1038/sj.emboj.7600900
8. NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages. S Asin GD Bern EM Carmona NJ Solan CV Paya, J Virol 2001 75 11408 16 11689622 10.1128/JVI.75.23.11408-11416.2001
9. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases. CJ Wu CY Leu ST Liu KP Chow CL Meng YS Chang, Gene Therapy 1998 5 905 12 9813661 10.1038/sj.gt.3300688
10. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy. AM Maatta A Tenhunen T Pasanen O Merilainen R Pellinen K Makinen E Alhava J Wahlfors, Int J Oncol 2004 24 943 9 15010834
11. Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: mechanisms of cell death induced by herpes simplex virus thymidine kinase/ganciclovir therapy. SS Neves AB Sarmento-Ribeiro SP Simoes MC Pedroso de Lima, Biochim Biophys Acta 2006 1758 1703 12 17049485 10.1016/j.bbamem.2006.08. 021
12. Sufasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. AR Pierre NK Minh-tuan L Freeric L Chantal J Olivilr EG Patricia R Bernard B Vincent, Int J Oncol 2007 30 283 290 17143539
13. Dexamethasone inhibits the HSV-tk/ganciclovir bystander effect in malignant glioma cells. AR Pierre NK Minh J Olivier R Bernard M Marie-Paule B Vincent, BMC Cancer 2005 5 32 15804364 10.1186/1471-2407-5-32
14. Interaction of Tumor Necrosis Factor Receptor2 associated Factors with the Latent Membrane Protein 1 Is Essential for Activation of NF-κB. CX Wang XY Li HH Gu XY Deng Y Cao, Prog Biochem Biophys 2001 28 240 45
15. Interference of Epigallocatechin-3-gallate on Targets of Nuclear FactorκB Signal Transduction Pathway Activated by EB Virus ncoded Latent Membrane Protein. Y Zhao FJ Luo FQ Tang M Tang Y CAO, Prog Biochem Biophys 2003 30 122 28
16. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Q Tang D Zhang M Wan L Jin, Cancer Biother Radiopharm 2007 22 755 61 18158766 10.1089/cbr.2007.346
17. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer. T Kagaya Y Nakamoto Y Sakai T Tsuchiyama H Yagita N Mukaida S Kaneko, Cancer Gene Ther 2006 13 357 66 16224495 10.1038/sj.cgt.7700908
18. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. AM Maatta S Korja H Venhoranta T Hakkarainen E Pirinen S Heikkinen R Pellinen K Makinen J Wahlfors, Int J Mol Med 2006 18 901 8 17016620
19. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer. H Ismoto A Ohtsuru V Braiden M Iwamatsu F Miki Y Kawashita Y Mizuta Y Kaneda S Kohno S Yamashita, Oncol Rep 2006 15 629 3 16465423